We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+7.29%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$22.1B
AUM Growth
+$302M
(+1.4%)
Cap. Flow
-$1.3B
Cap. Flow
% of AUM
-5.9%
Top 10 Holdings %
Top 10 Hldgs %
11.41%
Holding
3,562
New
1,146
Increased
641
Reduced
606
Closed
971
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$148M |
| 2 |
Netflix
NFLX
|
+$119M |
| 3 |
Airbnb
ABNB
|
+$111M |
| 4 |
XYZ
Block Inc
XYZ
|
+$89.5M |
| 5 |
Danaher
DHR
|
+$88.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charles River Laboratories
CRL
|
+$212M |
| 2 |
Alibaba
BABA
|
+$172M |
| 3 |
Zoetis
ZTS
|
+$133M |
| 4 |
TransUnion
TRU
|
+$124M |
| 5 |
Baidu
BIDU
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.88% |
| 2 | Financials | 13.4% |
| 3 | Consumer Discretionary | 12.06% |
| 4 | Technology | 11.2% |
| 5 | Communication Services | 8.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
Evercore
EVR
$11.8B
| $1.08M | ﹤0.01% |
+7,684
| New | +$1.07M |
|
1752
Five Below
FIVE
$11.6B
| $1.08M | ﹤0.01% |
5,596
-123,348
| -96% | -$23.6M |
|
1753
iShares MSCI Turkey ETF
TUR
$200M
| $1.08M | ﹤0.01% |
+51,198
| New | +$1.18M |
|
1754
ClearPoint Neuro
CLPT
$429M
| $1.08M | ﹤0.01% |
+56,391
| New | +$1.09M |
|
|
EARN
1755
Ellington Residential Mortgage REIT
EARN
$167M
| $1.07M | ﹤0.01% |
+91,339
| New | +$1.13M |
|
1756
TTM Technologies
TTMI
$11B
| $1.07M | ﹤0.01% |
+75,194
| New | +$1.12M |
|
1757
CALL
Gilead Sciences
GILD
$166B
| $1.07M | ﹤0.01% |
15,600
-24,500
| -61% | -$1.64M |
|
1758
Infosys
INFY
$50.3B
| $1.07M | ﹤0.01% |
+50,612
| New | +$967K |
|
1759
Incyte
INCY
$25.7B
| $1.07M | ﹤0.01% |
12,714
-82,440
| -87% | -$6.87M |
|
1760
PUT
Nike
NKE
$63.2B
| $1.07M | ﹤0.01% |
6,900
-36,300
| -84% | -$4.89M |
|
1761
Trinity Industries
TRN
$2.99B
| $1.06M | ﹤0.01% |
+39,530
| New | +$1.11M |
|
1762
Dynatrace
DT
$12.8B
| $1.06M | ﹤0.01% |
+18,181
| New | +$950K |
|
1763
State Street SPDR S&P Homebuilders ETF
XHB
$1.63B
| $1.06M | ﹤0.01% |
+14,421
| New | +$1.07M |
|
1764
iShares US Energy ETF
IYE
$1.73B
| $1.05M | ﹤0.01% |
+36,233
| New | +$1.01M |
|
1765
RLI Corp
RLI
$5.95B
| $1.05M | ﹤0.01% |
20,122
+8,298
| +70% | +$451K |
|
|
EBACW
1766
CALL
DELISTED
European Biotech Acquisition Corp. Warrant
EBACW
| $1.05M | ﹤0.01% |
+108,584
| New | +$101K |
|
|
JBGS
1767
JBG SMITH
JBGS
$856M
| $1.05M | ﹤0.01% |
+33,232
| New | +$1.08M |
|
1768
Halliburton
HAL
$26.4B
| $1.04M | ﹤0.01% |
+44,882
| New | +$997K |
|
|
CANO
1769
DELISTED
Cano Health, Inc.
CANO
| $1.04M | ﹤0.01% |
+857
| New | +$1.16M |
|
1770
BrightView Holdings
BV
$1.27B
| $1.03M | ﹤0.01% |
+64,157
| New | +$1.13M |
|
|
RPAI
1771
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $1.03M | ﹤0.01% |
+90,339
| New | +$1.06M |
|
1772
Siebert Financial
SIEB
$64.7M
| $1.03M | ﹤0.01% |
214,688
-61,277
| -22% | -$254K |
|
1773
Autodesk
ADSK
$51.5B
| $1.03M | ﹤0.01% |
3,531
-4,248
| -55% | -$1.21M |
|
1774
LSI Industries
LYTS
$855M
| $1.03M | ﹤0.01% |
+128,665
| New | +$1.08M |
|
1775
NOV
NOV
$7.19B
| $1.03M | ﹤0.01% |
67,295
+38,951
| +137% | +$606K |
|
Similar funds
Marshall Wace's Q2 2021 Portfolio in Review
As of Q2 2021, Marshall Wace held 3,562 positions worth $22.1B, up 1.4% from $21.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Marshall Wace withdrew a net $1.3B in Q2 2021, closing 971 positions and reducing 606 holdings. Its most notable exit was Pinterest, an estimated $88.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Marshall Wace opened a new position in West Pharmaceutical worth $55.8M.
- Marshall Wace's largest Q2 2021 buy was West Pharmaceutical: 155,316 shares worth $55.8M.
- Marshall Wace added most to Biogen in Q2 2021, an estimated $148M increase.
- Marshall Wace's biggest Q2 2021 reduction was Charles River Laboratories, cutting an estimated $212M.
- Marshall Wace fully exited Pinterest in Q2 2021, selling an estimated $88.8M.
- Marshall Wace's ten largest holdings make up 11% of its $22.1B portfolio in Q2 2021.
- Marshall Wace opened 1,146 new positions and closed 971 in Q2 2021.
- Marshall Wace's portfolio value rose 1.4% quarter-over-quarter to $22.1B.
Based on Marshall Wace's 13F filing for Q2 2021, filed 13 Aug 2021.